-
Recent Posts
- SoundBite Communications (NASDAQ: SDBT) Surges Following Acquisition Agreement
- Is Regenerative Medicine Realistic for YaFarm Technologies (PINKSHEETS: YFRM)?
- Can Raptor Pharmaceutical Corp. (NASDAQ: RPTP) Turn FDA Approval into Big Payday Down the Road?
- Camtek Ltd. (NASDAQ: CAMT) Shares Climb After First Quarter Growth and Positive Outlook
- Is There Hope for Next Generation Corp. (OTCQB: NGMC) in Oil and Gas Industry?
Categories
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tags
aapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks tradingSite
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Tag Archives: crl
NuPathe Inc. (NASDAQ: PATH) Inching Closer to PDUFA Date for Lead Product Migraine Patch, Will Second Time be the Charm?
With less than two months to go before NuPathe Inc. (NASDAQ: PATH) attempts to clear up any concerns about the safety, chemistry, and manufacturing processes of their lead product migraine patch, Zecuity, investors have been placing their bets on whether … Continue reading
Posted in Articles, NASDAQ
Tagged crl, fda, investors, migraine patch, migraines, nupathe, path, pdufa, pharmaceutical, safe, zecuity
Leave a comment
Can Dynavax Technologies Corp. (NASDAQ: DVAX) Overcome FDA Setback for HEPLISAV?
Shares of Dynavax Technologies Corp. (NASDAQ: DVAX) have been getting pounded on Friday following yesterday’s announcement that their lead product candidate HEPLISAV, an adult hepatitis B vaccine, failed to gain the support of an FDA advisory committee concerning safety issues. … Continue reading
Posted in Articles, NASDAQ
Tagged biopharmaceutical, crl, dvax, dynavax, fda, fda approval, hepatitis b, heplisav, investors, vaccine
Leave a comment
Future of Alexza Pharmaceuticals (NASDAQ: ALXA) Could be Determined Over the Next Six Months as NDA Ready for Submission to FDA Once More
With the resubmission of their New Drug Application to the FDA for AZ-004 now pushed back to August 8, 2011 shares in Alexza Pharmaceuticals (NASDAQ: ALXA) have dipped slightly, trading around the 1.47 – 1.53 range, sliding below their 50-day … Continue reading
Posted in Articles, NASDAQ, Penny Stocks
Tagged alexza pharmaceuticals, alxa, az-004, crl, drug delivery, fda, investors, loxapine, NASDAQ, nda, penny stocks, staccato
Leave a comment


